Inhibition of Early Atherogenesis by Losartan in Monkeys With Diet-Induced Hypercholesterolemia [PDF]
, 2000 William B. Strawn +4 more
openalex +1 more source
The losartan renal protection study — rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) [PDF]
, 2000 Barry M. Brenner +17 more
openalex +1 more source
Bushen Tongluo recipe improves oxidative stress homeostasis, inhibits transforming growth factor/Notch signaling pathway, and regulates the lncRNA maternally expressed gene 3/miR-145 axis to delay diabetic kidney disease. [PDF]
J Tradit Chin MedBojun XU +5 more
europepmc +1 more source
Active transport of the angiotensin‐II antagonist losartan and its main metabolite EXP 3174 across MDCK‐MDR1 and Caco‐2 cell monolayers [PDF]
, 2000 Andrea Soldner +3 more
openalex +1 more source
Is the combination of enalapril and losartan irrational?
Indian Journal of Pharmacology, 2008 Parmar, DM, Jadav, SP
openaire +4 more sources
Nephron progenitor fate is modulated by angiotensin type 1 receptor signaling in human kidney organoids. [PDF]
Stem CellsChung H +8 more
europepmc +1 more source
Effect of Indomethacin on Blood Pressure Lowering by Captopril and Losartan in Hypertensive Patients [PDF]
, 2000 Paul R. Conlin +7 more
openalex +1 more source
Efficacy of Nrf2 activation in a proteinuric Alport syndrome mouse model. [PDF]
Life Sci AllianceKaseda S +23 more
europepmc +1 more source
Haemodynamic, renal sodium handling, and neurohormonal effects of acute administration of low dose losartan, an angiotensin II receptor antagonist, in preascitic cirrhosis [PDF]
, 2000 Nigel Girgrah
openalex +1 more source
Balancing Yields and Sustainability: An Eco-Friendly Approach to Losartan Synthesis Using Green Palladium Nanoparticles. [PDF]
MoleculesAntunes EM +5 more
europepmc +1 more source